RFC

Russell Frank Company Portfolio holdings

AUM $56.9B
1-Year Est. Return 2.13%
This Quarter Est. Return
1 Year Est. Return
+2.13%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$56.9B
AUM Growth
-$371M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
3,191
New
Increased
Reduced
Closed

Top Buys

1 +$74.2M
2 +$69.5M
3 +$67.1M
4
ESS icon
Essex Property Trust
ESS
+$54M
5
DUK icon
Duke Energy
DUK
+$48M

Top Sells

1 +$87.7M
2 +$83.8M
3 +$77.6M
4
SBUX icon
Starbucks
SBUX
+$73.2M
5
RTX icon
RTX Corp
RTX
+$69.6M

Sector Composition

1 Financials 18.07%
2 Healthcare 12.54%
3 Technology 11.84%
4 Industrials 10.23%
5 Consumer Discretionary 9.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BDBD
2901
DELISTED
BOULDER BRANDS INC
BDBD
-192,712
RCAP
2902
DELISTED
RCS CAPITAL CORPORATION CLASS A COM
RCAP
-61,500
TW
2903
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
-22,281
KCLI
2904
DELISTED
KANSAS CITY LIFE INS CO NEW (MO)
KCLI
-14,784
PGN
2905
DELISTED
PARAGON OFFSHORE PLC (GBR)
PGN
-818
PHIIK
2906
DELISTED
PHI, Inc. Non-Voting Common Stock
PHIIK
-3,152
FBC
2907
DELISTED
Flagstar Bancorp, Inc. New
FBC
-2,222
WIBC
2908
DELISTED
WILSHIRE BANCORP INC
WIBC
-12,174
IMH
2909
DELISTED
Impac Mortgage Holdings Inc.
IMH
-2,888
CB
2910
DELISTED
CHUBB CORPORATION
CB
-415,775
LJPC
2911
DELISTED
La Jolla Pharmaceutical Company
LJPC
-23,536
PACD
2912
DELISTED
Pacific Drilling S A
PACD
-19,929
POM
2913
DELISTED
PEPCO HOLDINGS, INC.
POM
-97,209
LOCK
2914
DELISTED
LifeLock, Inc.
LOCK
-34,601
OREX
2915
DELISTED
Orexigen Therapeutics, Inc.
OREX
-5,258
AROW icon
2916
Arrow Financial
AROW
$503M
-1,809
ASML icon
2917
ASML
ASML
$427B
-182,685
ATRA icon
2918
Atara Biotherapeutics
ATRA
$103M
-212
AVNW icon
2919
Aviat Networks
AVNW
$270M
-6,305
BFIN icon
2920
BankFinancial
BFIN
$151M
-20,321
BH icon
2921
Biglari Holdings Class B
BH
$944M
-258
BOOT icon
2922
Boot Barn
BOOT
$6.16B
-28,880
CASH icon
2923
Pathward Financial
CASH
$1.66B
-42,060
CDE icon
2924
Coeur Mining
CDE
$10.2B
-20,134
SGMO icon
2925
Sangamo Therapeutics
SGMO
$167M
-76,760